Production (Stage)
Protara Therapeutics, Inc.
TARA
$3.34
$0.2156.89%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 125.20% | 159.67% | 10.08% | 11.47% | -36.24% |
| Total Receivables | 1,500.00% | -- | -- | -- | -95.32% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -20.80% | 4.39% | 60.96% | 25.15% | -1.14% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -40.99% | -53.11% | -9.36% | -41.94% | -75.82% |
| Total Current Assets | 118.49% | 150.57% | 9.34% | 9.43% | -38.79% |
|
|
|||||
| Total Current Assets | 118.49% | 150.57% | 9.34% | 9.43% | -38.79% |
| Net Property, Plant & Equipment | -20.08% | -19.48% | -19.30% | -17.89% | -17.63% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -2.43% | 8.89% | -8.17% | -4.03% | 199.77% |
| Total Assets | 147.39% | 129.82% | 6.36% | 6.84% | -35.97% |
|
|
|||||
| Total Accounts Payable | 137.65% | 81.96% | -8.35% | -25.22% | -76.18% |
| Total Accrued Expenses | 0.26% | 97.95% | 59.39% | 51.48% | 152.79% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 17.00% | 14.34% | 11.70% | 9.06% | 7.18% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 27.58% | 78.26% | 27.56% | 14.52% | -14.18% |
|
|
|||||
| Total Current Liabilities | 27.58% | 78.26% | 27.56% | 14.52% | -14.18% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -27.68% | -25.09% | -22.78% | -20.77% | -19.13% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.57% | 34.68% | 6.85% | -3.22% | -16.40% |
|
|
|||||
| Common Stock & APIC | 53.88% | 53.35% | 17.47% | 17.75% | 2.13% |
| Retained Earnings | -21.47% | -22.26% | -22.11% | -22.57% | -25.13% |
| Treasury Stock & Other | 9,000.00% | 106.45% | 117.58% | -- | 99.79% |
| Total Common Equity | 171.35% | 144.63% | 6.28% | 8.01% | -38.37% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 171.35% | 144.63% | 6.28% | 8.01% | -38.37% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 171.35% | 144.63% | 6.28% | 8.01% | -38.37% |
|
|
|||||